Please login to the form below

Not currently logged in
Email:
Password:

Lucid strikes £11m investment deal with equity firm LDC

Will use the new funds to underpin its infrastructure as it grows

Lucid Group Lucid has agreed an £11m investment deal with private equity company LDC to support its US expansion and increase its infrastructure.

The medical communications group has been growing rapidly, most recently launching a new strategic consultancy and winning a Queen’s Award for international trade earlier this year.

Its agreement with LDC will see the firm, which is the private equity arm of the UK’s Lloyds Banking Group, take a minority investment in Lucid.

LDC investment directors Christian Bruning and Rob Apollo will join the group’s board, with Tim Trotter - current chairman of PEI Media and chief executive chairman of Ludgate Group - appointed as non-executive chairman as a part of the deal.

Lucid’s founders Dennis O’Brien and Jan Steele will continue to lead the business.

O’Brien said: “We felt the time was right to bring on board a strategic partner, and in LDC we have an experienced investor with a strong track record in the healthcare sector.

“From the outset, they have had a flexible approach to the investment, structuring the deal on terms that worked for us.

“We’re now best placed to maximise the growth potential of Lucid and solidify our position as thought leaders and innovators in the medical education market.”

Lucid, which employs over 100 people, has offices in London, Beaconsfield and New York, and has seen a 30% growth in the past two years.

Christian Bruning, investment director at LDC London, said: “In Dennis, Jan and their management we have an experienced team at the helm of the business and we look forward to working alongside them to support the next phase of growth and expansion to build further on the Lucid brand.

Article by
Gemma Jones

12th June 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics